You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

AMPICILLIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Ampicillin patents expire, and what generic alternatives are available?

Ampicillin is a drug marketed by Acs Dobfar, Antibiotice, Astral, Eugia Pharma Speclts, Hikma, Hospira Inc, Hq Speclt Pharma, Istituto Bio Ita Spa, Medimetriks Pharms, Sandoz, Steriscience Speclts, Acs Dobfar Spa, Apothecon, Consolidated Pharm, Hospira, Intl Medication, Lilly, Sagent Pharms Inc, Watson Labs Inc, Aurobindo Pharma, Belcher Pharms, Chartwell Rx, Ivax Sub Teva Pharms, Lederle, Mylan, Purepac Pharm, Strides Pharma, Vitarine, Endo Operations, and Teva. and is included in sixty-four NDAs.

The generic ingredient in AMPICILLIN is ampicillin/ampicillin trihydrate. Three suppliers are listed for this compound. Additional details are available on the ampicillin/ampicillin trihydrate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AMPICILLIN?
  • What are the global sales for AMPICILLIN?
  • What is Average Wholesale Price for AMPICILLIN?
Drug patent expirations by year for AMPICILLIN
Drug Prices for AMPICILLIN

See drug prices for AMPICILLIN

Drug Sales Revenue Trends for AMPICILLIN

See drug sales revenues for AMPICILLIN

US Patents and Regulatory Information for AMPICILLIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 202864-002 Sep 4, 2015 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 061395-006 Approved Prior to Jan 1, 1982 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Acs Dobfar Spa AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 090884-001 Apr 3, 2013 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz AMPICILLIN AND SULBACTAM ampicillin sodium; sulbactam sodium INJECTABLE;INJECTION 065241-002 Jul 25, 2006 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.